Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Currently, embryo implantation success rates in in vitro fertilization (IVF) are low, partly due to subjective and invasive tests. An assay that can quantify embryo potential while preserving its integrity is necessary. Small RNA sequences, microRNAs (miRNAs), are promising, quantifiable, and non-intrusive markers of developmental potential in embryos. Due to ethical concerns with human embryos in research, an alternative model is needed. Recent findings demonstrate the ability of human embryonic stem cells to self-organize into pre-implantation analogues known as blastoids, but it is unknown if blastoids also release development-specific miRNA. We aim to demonstrate blastoids as a model for human embryo potential using miRNAs and ultimately develop an accurate and efficient embryo selection assay. This will improve IVF accessibility, affordability, success rates, and patient satisfaction while reducing operational expenses. Implementing this advanced technology will give the fertility clinic a competitive advantage, enhancing its long-term reputation for trust and credibility.
Dean Betts
London Health Sciences Centre
Life Sciences
Health and Related Sciences & Technology
The University of Western Ontario
Accelerate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.